Eye Laser Industry - VISX and Summit BEAM Info Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eye Laser Industry - VISX and Summit BEAM Info

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert Northington who wrote (16)	8/19/1996 10:49:00 PM
From: AgAuUSA	of 178

Robert, Actually, I find it quite interesting that the CHIR CEO bought 100,000 shares in the $94.00 (presplit) range in the spring of 96. I believe that the stock price has traded down due to analysts perception of declining earnings. Most recent earnings were from a gain on a sale. Actual per share earnings were less than expected. That sent the stock careening. Additionally, analysts were saying that Chir is now a diagnostics company not a biotech company. I feel they got that totally wrong. I do my own research and I do not believe you should buy a biotech stock for earnings reasons. CHIR has excellent prospects for profitability in the future however. CHIR's true value is in the breadth and depth of their scientific endeavors. For a company with CHIR's market cap you will not find a better group of scientists and research program. You cannot go wrong buying CHIR at the current price. Just hold and be patient. I have been buying and intend to continue to add to my position on weakness. Greg

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next